The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q3 2023 call → NOWe need to determine if management conveys that the reported results do not represent the business as it is actually running today. The key is whether management indicates a gap between the period's numbers and the current state of the business, grounded in concrete actions/activities already underway. Look for statements: CTEH normalization expected in Q4, meaning Q3 had elevated CTEH revenue from responses that have tailed off. They state "large response has now tailed off" but still had impact in Q3. CTEH will be below normalized levels in Q4. This indicates the reported period (Q3) had an elevated level that is not the run rate. However, the business is reverting to normal, not ahead. They also mention pivoting away from lower margin revenue, especially in biogas, which impacted reported results but is a deliberate shift. They say "pivot away from lower margin revenue" and "focus on higher margin, lower revenue services." This suggests the reported period includes some of that lower margin revenue that they are exiting. So the current business is higher margin but lower revenue? They say "pivot away from lower margin revenue" meaning they are shedding it, so the period's results still include it. They also mention "strategic shift in our biogas business to focus on higher margin, lower revenue services." So the reported period reflects higher revenue but lower margin, and the company is moving to higher margin but lower revenue. That is a shift that may make current run rate different from reported. Also, acquisitions like Matrix contributed, but Matrix is seasonally dilutive. They expect margins to improve. But the question: Does management convey that the reported results do not represent the business currently running? Are they saying the business ahead of the period? The theme: "we are reiterating guidance" and "strong performance." They note CTEH will be lighter in Q4, meaning Q3 had peak. They also mention "we focused 2023 on delivering adjusted EBITDA targets and increasing margin, achieving both." They talk about "pivot away from lower margin revenue, particularly ECT2 biogas services." This suggests the reported period includes that lower margin revenue. The business is now run differently, so the period's numbers are stale.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.